The has announced gifts totaling $75 million from the to the at UT Austin and the in Houston.
A gift of $50 million will create the at DMS in support of neuroscience patient care, research, and clinical operations, with an initial focus on Alzheimer's disease, Parkinson's disease, stroke, and bipolar disorder. And a gift of $25 million will fund MD Anderson's efforts to improve treatments for and significantly reduce deaths from melanoma and prostate cancer.
Previous support from the Mulva Family Foundation for UT Austin and MD Anderson includes multiyear pledges of $40 million for the , $20 million for the , $15 million for the new Liberal Arts Building, and $5 million to the Miriam and Jim Mulva Fund for Melanoma Research. A graduate of UT Austin, Jim Mulva is former chair and CEO of ConocoPhillips and chair of the MD Anderson Cancer Center Board of Visitors.
"This transformational gift is a reflection of the Mulva family's extraordinary generosity and dedication to advancing the fight to end two of our most menacing foes — melanoma, the deadliest form of skin cancer; and prostate cancer, the second leading cause of cancer deaths in men," said MD Anderson president Ronald A. DePinho. "We are profoundly grateful for the Mulva Family Foundation's remarkable support of MD Anderson's mission. Together, we will change the statistics and create new hope for patients and their loved ones facing the challenges of cancer."